Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients

Published:2014-04-12 Issue:6 Volume:261 Page:1170-1177
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Sorensen Per Soelberg,Koch-Henriksen Nils,Petersen Thor,Ravnborg Mads,Oturai Annette,Sellebjerg Finn

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-014-7325-8.pdf

Reference25 articles.

1. O’Connor PW, Goodman A, Kappos L, Lublin FD, Miller DH, Polman C et al (2011) Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology 76(22):1858–1865

2. Stuve O, Cravens PD, Frohman EM, Phillips JT, Remington GM, von Geldern G et al (2009) Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Neurology 72(5):396–401

3. West TW, Cree BA (2010) Natalizumab dosage suspension: are we helping or hurting? Ann Neurol 68(3):395–399

4. Kerbrat A, Le PE, Leray E, Anani T, Coustans M, Desormeaux C et al (2011) Natalizumab and drug holiday in clinical practice: an observational study in very active relapsing remitting multiple sclerosis patients. J Neurol Sci 308(1–2):98–102

5. Rigau V, Mania A, Befort P, Carlander B, Jonquet O, Lassmann H et al (2012) Lethal multiple sclerosis relapse after natalizumab withdrawal. Neurology 79(22):2214–2216

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurring disease activity in relapsing remitting multiple sclerosis: The multicenter RDA-RMS study;Multiple Sclerosis and Related Disorders;2024-08

2. Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study;Journal of Neurology;2024-02-29

3. Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis;Pharmaceutics;2024-01-17

4. Immune cell reconstitution following autologous hematopoietic stem cell transplantation in multiple sclerosis;Handbook of Clinical Neurology;2024

5. Multiple faces of multiple sclerosis in the era of highly efficient treatment modalities: Lymphopenia and switching treatment options challenges daily practice;International Immunopharmacology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3